Tuberculosis is still in 2024 the 2e infectious disease which kills the most. Despite the setback due to the Covid-19 in 2020, we strongly keep fighting, aiming for 2030 eradication objective set by the World Health Organization (WHO).
new cases of tuberculosis each year.
deaths linked to tuberculosis in 2022, mainly due to inequitable access to care.
Deaths among people living with HIV, representing 1/3 of deaths in this population directly attributable to tuberculosis.
Persistent and emerging obstacles
Growing crises – consequences of climate change, political and economic instability – are widening inequalities and reducing access to care for populations. Despite the efforts and progress of countries, this situation brings big challenges in terms of screening, diagnosis and treatment resistance.
- 2 à 4 millions
de cas manquants de tuberculose/an
c’est-à-dire non notifiés par les systèmes de santé, donc n’ayant pas accès aux soins indispensables à leur guérison.
- 1/3 des malades
ayant accès aux traitements
Pourtant, 85% des personnes qui développent la maladie peuvent être traitées avec succès grâce à un schéma thérapeutique de 4 à 6 mois.
- 410 000 cas
de tuberculose résistante
notifiés en 2022. Parmi elles, seules 2 personnes sur 5 ont eu accès à un traitement adéquat.
Better detect and manage latent tuberculosis
Meet a beneficiary family to better understand the ins and outs of the APRECIT project, carried out with the Mérieux Foundation and the National Tuberculosis Control Program in Cameroon and Madagascar. Discover our report on the silent form of the disease, blind spot in the fight, and the way we manage to control it.
To fight drug-resistant tuberculosis: Strenghtening health structures
Germs responsible for tuberculosis develop severe resistance to treatments, complicating the fight against the disease and deteriorating the quality of life of patients. To improve the accessibility and effectiveness of medicines, The Initiative works to train human resources in health and to increase capacity building.
Target and adapt: Focus on our action
To fulfill our mission and move towards a world free from the burden of tuberculosis (but also AIDS and malaria), we priorize investments with a catalytic effect, focusing on community commitment, gender equality and human rights as well as health systems systainability and equity to access.
committed overall to fight against tuberculosis between 2019 and 2023.
that we support have at least one tuberculosis component, including 14 exclusively dedicated to this pandemic.
that we support have at least one tuberculosis component, including 45 exclusively dedicated to this pandemic.
Our action by key figures
Between South-East Asia and Africa, discover the implementation of our projects and technical assistance. These initiatives are carried out in a logic of commitment of all partners involved in the fight, from NGOs to research institutes, including civil society and international donor institutions.
One podcast to learn everything about tuberculosis
In December 2023, a multidisciplinary masterclass host by the Pasteur Center of Cameroon was bringing together young doctors from all over Africa. It aimed to train the next generation of scientists to research in the pandemic. Let’s discover our serie of interviews and explore unexpected approaches to tackle the disease.
Tuberculosis: The voices of research
Clinicians, anthropologists, economists… A variety of doctors give you the keys to understand the epidemic. Community health, One Health approach or stigmatisation impact on patients: discover the thousand facets of the fight against this historic pandemic. A podcast to listen to on all your favorite platforms.
Tuberculose : les voix de la recherche
Cliniciens, anthropologues, économistes… Les chercheurs vous livrent les clés pour comprendre l’envers d’une épidémie aux embranchements parfois insoupçonnés. Santé communautaire, prisme One Health (Une seule santé) ou encore poids des représentations sociales, découvrez les mille facettes de lutte contre cette pandémie historique. Un podcast disponible sur toutes vos plateformes d’écoutes préférées.
